124 related articles for article (PubMed ID: 33797866)
1. Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scores.
Sasaki K; Gagnière J; Dupré A; Ardiles V; O'Connor JM; Wang J; Moro A; Morioka D; Buettner S; Gau L; Ribeiro M; Wagner D; Andreatos N; Løes IM; Fitschek F; Kaczirek K; Lønning PE; Kornprat P; Poultsides G; Kamphues C; Imai K; Baba H; Endo I; Kwon CHD; Aucejo FN; de Santibañes E; Kreis ME; Margonis GA
J Hepatobiliary Pancreat Sci; 2021 Jul; 28(7):581-592. PubMed ID: 33797866
[TBL] [Abstract][Full Text] [Related]
2. Performance of prognostic models incorporating KRAS mutation status to predict survival after resection of colorectal liver metastases.
Wong GYM; Bhimani N; Mol B; Diakos C; de Reuver P; Molloy MP; Hugh TJ
HPB (Oxford); 2022 Aug; 24(8):1316-1325. PubMed ID: 35093297
[TBL] [Abstract][Full Text] [Related]
3. Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
Margonis GA; Sasaki K; Gholami S; Kim Y; Andreatos N; Rezaee N; Deshwar A; Buettner S; Allen PJ; Kingham TP; Pawlik TM; He J; Cameron JL; Jarnagin WR; Wolfgang CL; D'Angelica MI; Weiss MJ
Br J Surg; 2018 Aug; 105(9):1210-1220. PubMed ID: 29691844
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
[TBL] [Abstract][Full Text] [Related]
5. Nontumor related risk score: A new tool to improve prediction of prognosis after hepatectomy for colorectal liver metastases.
Sasaki K; Margonis GA; Moro A; Wang J; Wagner D; Gagnière J; Shin JK; D'Silva M; Sahara K; Miyata T; Kusakabe J; Beyer K; Dupré A; Kamphues C; Imai K; Baba H; Endo I; Taura K; Cho JY; Aucejo F; Kornprat P; Kreis ME; Kim JM; Burkhart R; David Kwon CH; Pawlik TM
Surgery; 2022 Jun; 171(6):1580-1587. PubMed ID: 35221105
[TBL] [Abstract][Full Text] [Related]
6. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
7. A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases.
Paredes AZ; Hyer JM; Tsilimigras DI; Moro A; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Makris EA; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
Ann Surg Oncol; 2020 Dec; 27(13):5139-5147. PubMed ID: 32779049
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation.
Chen Y; Chang W; Ren L; Chen J; Tang W; Liu T; Jian M; Liu Y; Wei Y; Xu J
Oncologist; 2020 Jul; 25(7):e1031-e1041. PubMed ID: 32181531
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
[TBL] [Abstract][Full Text] [Related]
10. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
11. Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases.
Bohlok A; Duran Derijckere I; Azema H; Lucidi V; Vankerckhove S; Hendlisz A; Van Laethem JL; Vierasu I; Goldman S; Flamen P; Larsimont D; Demetter P; Dirix L; Vermeulen P; Donckier V
J Surg Oncol; 2021 May; 123(8):1773-1783. PubMed ID: 33751583
[TBL] [Abstract][Full Text] [Related]
12. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases.
Mann CD; Metcalfe MS; Leopardi LN; Maddern GJ
Arch Surg; 2004 Nov; 139(11):1168-72. PubMed ID: 15545561
[TBL] [Abstract][Full Text] [Related]
13. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
Schmidt T; Nienhüser H; Kuna C; Klose J; Strowitzki MJ; Büchler MW; Ulrich A; Schneider M
Eur J Surg Oncol; 2018 Oct; 44(10):1610-1618. PubMed ID: 30115500
[TBL] [Abstract][Full Text] [Related]
16. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
[TBL] [Abstract][Full Text] [Related]
17. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
18. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
[TBL] [Abstract][Full Text] [Related]
19. Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.
Barkhatov L; Fretland ÅA; Kazaryan AM; Røsok BI; Brudvik KW; Waage A; Bjørnbeth BA; Sahakyan MA; Edwin B
J Surg Oncol; 2016 Nov; 114(6):757-763. PubMed ID: 27471127
[TBL] [Abstract][Full Text] [Related]
20. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
